Genentech drug linked to death

Genentech Inc. said a second patient taking its psoriasis treatment, Raptiva, had developed a rare brain infection.

A 73-year-old woman died from progressive multifocal leukoencephalopathy after taking Raptiva, South San Francisco-based Genentech said.

Genentech reported Oct. 2 that a 70-year-old patient taking the drug for more than four years developed PML.